- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/64 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
Patent holdings for IPC class C07D 211/64
Total number of patents in this class: 19
10-year publication summary
|
0
|
3
|
0
|
2
|
1
|
0
|
2
|
1
|
0
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mayo Foundation for Medical Education and Research | 3295 |
4 |
| Boehringer Ingelheim International GmbH | 4636 |
2 |
| F. Hoffmann-La Roche AG | 7937 |
1 |
| Hoffmann-La Roche Inc. | 3546 |
1 |
| The Board of Trustees of the University of Illinois | 2724 |
1 |
| 92229129 Quebec Inc. | 5 |
1 |
| Chugai Seiyaku Kabushiki Kaisha | 1379 |
1 |
| D. E. Shaw Research, LLC | 10 |
1 |
| Industry-Academic Cooperation Foundation, Yonsei University | 2422 |
1 |
| MethylGene Inc. | 40 |
1 |
| 7503547 Canada, Inc. | 5 |
1 |
| Firmenich Incorporated | 155 |
1 |
| sanofi-aventis | 346 |
1 |
| Sumitomo Pharma Co., Ltd. | 510 |
1 |
| Ube Corporation | 411 |
1 |
| Other owners | 0 |